InnoRx
Irvine
About InnoRx
InnoRx, Inc., a development stage company, develops novel therapies for the ophthalmology market. The company focuses on the development of drugs and drug delivery systems for ocular disease. Its products target age-related macular degeneration (AMD) and diabetic macular edema (DME).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/innorx-1071945 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.